DrugPatentWatch Database Preview
Patent: 8,344,153
Summary for Patent: 8,344,153
| Title: | Inhibitors of phosphatidylinositol 3-kinase |
| Abstract: | The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3K.gamma.. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. |
| Inventor(s): | Cottrell; Kevin Michael (Cambridge, MA), Aronov; Alex (Newton, MA), Davies; Robert J. (Watertown, MA), Come; Jon H. (Cambridge, MA), Messersmith; David (Somerville, MA), Xu; Jinwang (Framingham, MA), Bandarage; Upul Keerthi (Lexington, MA), Cao; Jingrong (Newton, MA) |
| Assignee: | Vertex Pharmaceuticals Incorporated (Cambridge, MA) |
| Application Number: | 12/796,825 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,344,153
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Idec | TYSABRI | natalizumab | VIAL; SINGLE-USE | 125104 | 001 | 2004-11-23 | Start Trial | Vertex Pharmaceuticals Incorporated (Cambridge, MA) | 2029-06-10 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,344,153
| Country | Patent Number | Publication Date |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2010144513 | Dec 16, 2010 |
| United States of America | 2010316605 | Dec 16, 2010 |
| Mexico | 2011013032 | Feb 08, 2012 |
| Japan | 2012529525 | Nov 22, 2012 |
| European Patent Office | 2440556 | Apr 18, 2012 |
| China | 102548990 | Jul 04, 2012 |
| Canada | 2764989 | Dec 16, 2010 |
| >Country | >Patent Number | >Publication Date |
